![]() |
市場調査レポート
商品コード
1764139
細胞分離市場- 世界の産業規模、シェア、動向、機会、予測、細胞タイプ別、用途別、地域別、競合別、2020-2030年Cell Isolation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Cell Type, By Application, By Region and Competition, 2020-2030F |
||||||
カスタマイズ可能
|
細胞分離市場- 世界の産業規模、シェア、動向、機会、予測、細胞タイプ別、用途別、地域別、競合別、2020-2030年 |
出版日: 2025年06月30日
発行: TechSci Research
ページ情報: 英文 185 Pages
納期: 2~3営業日
|
細胞分離の世界市場は、2024年に34億7,000万米ドルと評価され、2030年には47億6,000万米ドルに達し、CAGR 5.62%で拡大すると予測されています。
細胞分離(混合集団から特定の細胞タイプを分離するプロセス)は、再生医療、がん研究、免疫療法、幹細胞生物学などの分野で基礎となっています。ライフサイエンス分野の進歩に伴い、高純度で生存可能な細胞への需要が高まり、細胞分離の精度、拡張性、効率を高める技術への投資が増加しています。
市場概要 | |
---|---|
予測期間 | 2026-2030 |
市場規模:2024年 | 34億7,000万米ドル |
市場規模:2030年 | 47億6,000万米ドル |
CAGR:2025年~2030年 | 5.62% |
急成長セグメント | ヒト細胞 |
最大市場 | 北米 |
成長の主な原動力は、個別化医療の採用が拡大していることです。個別化医療は、標的治療の開発のために患者固有の細胞を分離することに依存しています。このニーズは、免疫療法や細胞ベースの治療が正確な細胞選択を必要とする腫瘍学において特に顕著です。高いコストと技術的障壁が課題-特に希少な細胞やデリケートな細胞の分離-となっているが、アジア太平洋地域の新興市場は、ヘルスケア・インフラ、研究能力、医薬品製造への投資の拡大に支えられ、新たな拡大機会を生み出しています。
ヘルスケア産業の成長
細胞分離技術の高コスト
細胞ベースの治療に対する需要の増加
The Global Cell Isolation Market was valued at USD 3.47 billion in 2024 and is projected to reach USD 4.76 billion by 2030, expanding at a CAGR of 5.62%. Cell isolation-the process of separating specific cell types from a mixed population-is fundamental in fields such as regenerative medicine, cancer research, immunotherapy, and stem cell biology. As the life sciences sector advances, the demand for high-purity and viable cells is driving increased investment in technologies that offer enhanced precision, scalability, and efficiency in cell separation.
Market Overview | |
---|---|
Forecast Period | 2026-2030 |
Market Size 2024 | USD 3.47 Billion |
Market Size 2030 | USD 4.76 Billion |
CAGR 2025-2030 | 5.62% |
Fastest Growing Segment | Human Cells |
Largest Market | North America |
A primary growth driver is the growing adoption of personalized medicine, which depends on isolating patient-specific cells for the development of targeted therapies. This need is particularly prominent in oncology, where immunotherapies and cell-based treatments require accurate cell selection. While high costs and technical barriers pose challenges-especially in isolating rare or delicate cell types-emerging markets in the Asia-Pacific region are creating new opportunities for expansion, supported by growing investments in healthcare infrastructure, research capabilities, and pharmaceutical manufacturing.
Key Market Drivers
Growth in Healthcare Industry
The expansion of the global healthcare industry is a central factor driving the growth of the cell isolation market. With annual revenues exceeding USD 4 trillion, healthcare is supported by key sectors such as pharmaceuticals and biotechnology, contributing nearly USD 850 billion, and medical technology and diagnostics, which account for over USD 400 billion. This industry growth-especially in emerging economies-is accelerating the adoption of advanced diagnostic and therapeutic tools, including cell-based solutions.
As hospitals, laboratories, and pharmaceutical firms increasingly invest in regenerative therapies and precision medicine, the demand for scalable and reliable cell isolation techniques is rising. Additionally, the increasing global prevalence of chronic illnesses, including cancer and autoimmune diseases, has intensified the need for targeted therapies. In 2021, noncommunicable diseases were responsible for over 43 million deaths globally, with the majority occurring prematurely in low- and middle-income countries-reinforcing the importance of cell-based technologies for future treatment protocols.
Key Market Challenges
High Cost of Cell Isolation Technologies
The high cost associated with cell isolation technologies continues to be a major limitation for broader adoption, particularly in resource-limited settings. Systems like fluorescence-activated cell sorting (FACS) and magnetic-activated cell sorting (MACS) require sophisticated instruments, proprietary reagents, and specialized personnel, all contributing to significant operational costs.
These expenses present a substantial barrier for smaller laboratories, academic institutions, and biotech startups. Moreover, ongoing costs-such as maintenance, consumables, and technical support-can hinder the full utilization of cell isolation tools, especially in developing countries where funding and access to infrastructure are limited.
Key Market Trends
Increased Demand for Cell-Based Therapies
A key trend influencing the cell isolation market is the rising demand for cell-based therapies. By 2035, treatments such as CAR-T, TCR, and TIL therapies are expected to make up over 45% of clinical demand for cell therapy products. These therapies are gaining traction for their ability to address a wide array of diseases, including cancer, autoimmune conditions, and degenerative disorders.
This shift toward cell-based interventions is driving the need for robust isolation technologies that can reliably deliver high-quality, contamination-free, and functional cells. As the industry focuses more on precision medicine, the development and clinical use of cell therapies require advanced systems capable of delivering consistent and reproducible results in complex workflows.
Report Scope
In this report, the Global Cell Isolation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Cell Isolation Market.
Available Customizations
Global Cell Isolation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: